Borussia Dortmund GmbH & Co KGaA (BVB)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 3.095 |
|---|---|
| 52-week range | 2.860 – 3.570 |
| Return, 1 month / 3 months | −2.2% / +1.1% |
| Return, 1 year / 3 years | −8.9% / −14.2% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 16.6% |
| Worst drawdown (1 year) | -12.9% |
| Average daily value traded | 0.28M EUR |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Borussia Dortmund GmbH & Co KGaA operates the Borussia Dortmund football club, which plays in the German Bundesliga. The club earns money from home match tickets, television and media rights, shirt and stadium sponsorship, and the sale of merchandise such as kits and fan articles. It also develops players through its youth academy and transfers professionals to other clubs. The business is based in Dortmund, Germany, and its customers are football supporters, broadcasters, sponsors and commercial partners.
The shares are listed on the Deutsche Börse Xetra in Germany under the code BVB, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Borussia Dortmund GmbH & Co KGaA (BVB) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 3.095 on 27 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 233 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.9% and over the last three months it rose 1.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.0% | ||
| From 52-week high | -10.8% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.1% | ||
| 6-month return | -4.2% | ||
| 12-month return, skipping the last month | -6.9% | ||
| Stability (higher is calmer) | 96 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.9% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.28M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 22 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | −2.2% |
| 3 months | +1.1% |
| 6 months | −4.2% |
| 1 year | −8.9% |
| 3 years | −14.2% |
| 5 years | −32.3% |
Signals
| 50-day / 200-day average | 3.158 / 3.127 |
|---|---|
| Golden / death cross (60 days) | Golden, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.053 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Nov 2025 | EUR 0.0600 |
| 26 Nov 2024 | EUR 0.0600 |
| 26 Nov 2019 | EUR 0.0600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.